SNSS

Sunesis Pharmaceuticals Stock Price

0.3061
0.0092 (3.1%)
Upgrade to Real-Time
Regular Market
0.3061
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Sunesis Pharmaceuticals Inc SNSS NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.0092 3.1% 0.3061 0.285 0.3084 0.2965 0.2969 12:59:19
Bid Price Ask Price Spread Spread % News
0.3022 0.3061 0.0039 1.27% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
7,935 9,054,082 $ 0.2922001 $ 2,645,604 17,263,239 0.1951 - 1.17
Last Trade Time Type Quantity Stock Price Currency
12:59:19 780 $ 0.3061 USD

Sunesis Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 32.17M 111.39M 106.26M $ 2.07M $ - -0.29 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Sunesis Pharmaceuticals News

Date Time Source News Article
8/04/202007:00GlobeNewswire Inc.Sunesis Pharmaceuticals to Host Conference Call on August..
8/03/202010:19Edgar (US Regulatory)Statement of Ownership (sc 13g)
7/31/202006:24Edgar (US Regulatory)Current Report Filing (8-k)
7/30/202018:56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
7/29/202011:06Edgar (US Regulatory)Statement of Ownership (sc 13g)
7/29/202009:05GlobeNewswire Inc.Sunesis Announces Pricing of $12 Million Offering of Common..
7/28/202017:03Edgar (US Regulatory)Current Report Filing (8-k)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SNSS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.2920.350.260.294873124,634,3570.01414.83%
1 Month0.3050.6140.2390.321373319,132,8180.00110.36%
3 Months0.38780.700.2390.343298910,373,554-0.0817-21.07%
6 Months0.671.170.2390.38757935,589,447-0.3639-54.31%
1 Year0.761.170.19510.40297353,404,956-0.4539-59.72%
3 Years2.52817.690.19510.61809251,449,936-2.22-87.89%
5 Years1.357.690.19510.6910584980,955-1.04-77.33%

Sunesis Pharmaceuticals Description

Sunesis Pharmaceuticals Inc is a US-based biopharmaceutical company. It focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The product portfolio of the company includes Vosaroxin which is an anticancer quinolone derivative for the treatment of acute myeloid leukemia (AML). The company's other kinase inhibitor pipeline includes TAK-580, SNS-062, and SNS-229. Further, the firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The firm derives substantially the majority of revenue from license and collaboration agreements.
Your Recent History
NASDAQ
SNSS
Sunesis Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200806 17:14:21